Insulet Corp.
PODD
주식 순위
#2089
Insulet Corporation develops, manufactures, and sells insulin delivery systems... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
주가
$142.76
시가총액
$9.90B
변동 (1일)
0.08%
변동 (1년)
-56.60%
국가
US
거래 Insulet Corp. (PODD)
카테고리
Healthcare
Insulet Corp. (PODD)의 주가 이력
최고 종가: $137.04 (2026-10-01 기준)
최저 종가: $15.32 (2007-05-01 기준)
최저 종가: $15.32 (2007-05-01 기준)
Insulet Corp.의 주가 이력 (2007 ~ 2026)
연간 주가 성과
| 연도 | 성과 |
|---|---|
| 2026 (TTM) | -28.61% |
| 2025 | 10.94% |
| 2024 | 29.28% |
| 2023 | -31.55% |
| 2022 | 12.13% |
| 2021 | 7.15% |
| 2020 | 41.98% |
| 2019 | 122.73% |
| 2018 | 14.06% |
| 2017 | 87.47% |
| 2016 | -0.45% |
| 2015 | -18.45% |
| 2014 | 23.64% |
| 2013 | 70.93% |
| 2012 | 17.30% |
| 2011 | 23.42% |
| 2010 | 14.55% |
| 2009 | 83.92% |
| 2008 | -70.52% |
| 2007 | 0.00% |
유사 기업 또는 경쟁사의 주가
| 회사 | 주가 | 변동률 1년% | 국가 |
|---|---|---|---|
| $99.24 | -22.19% |
US
|
|
| $92.83 | -3.13% |
IE
|
|
| $295.54 | -22.18% |
US
|
|
| $44.16 | -55.80% |
US
|
|
| $46.69 | -17.17% |
DE
|
